To the Editor:
We read the article by Conway et al
1
with great interest; however, we think some methodologic and statistical issues should be taken into account to avoid misinterpretation.The authors
1
stated that predictors with P values < .05 in univariate analysis were considered further for multivariable analysis. It is important to emphasize that such a univariate criterion can increase the risk of Testimation bias in the resulting effect estimates.2
, 3
Testimation bias will occur when a conservative univariate P value is considered in multivariable analysis.2
The authors studied the effect of several baseline and clinical patient characteristics on death in univariate analysis.1
Some of them had a relatively large effect; for example, those with P < .05 and some others had a relatively small effect (eg, body mass index with P = .06 in univariate analysis).1
When predictors with relatively large effect only are included in multivariable analysis, the effect of such predictors will be overestimated.2
Such overestimation of effects of strong predictors is known as Testimation bias.2
To reduce this bias several strategies have been suggested. For example, a liberal univariate P value < .10 or < .20 can be considered in multivariable analysis or predictors can be selected based on both statistical test and clinical relevancy.2
Moreover, the authors1 point out that external validity of the results may be low. We think internal validity of the results is still questionable. Cross-validation and bootstrapping are efficient strategies for checking internal validity of results.
2
A take-home message for readers is that the estimated odds ratios for the predictors of death in patients treated with intravenous vancomycin therapy should be considered along with the degree of Testimation bias.
References
- Decreased mortality in patients prescribed vancomycin after implementation of antimicrobial stewardship program.Am J Infect Control. 2017; 45: 1194-1197
- Clinical prediction models: a practical approach to development, validation, and updating.Springer Science & Business Media, 2008
- Incidence and risk factors for surgical site infection posthysterectomy in a tertiary care center: Methodologic issues.Am J Infect Control. 2017; 45: 580-581
Article info
Publication history
Published online: January 09, 2018
Footnotes
Conflicts of interest: None to report.
Identification
Copyright
© 2018 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
ScienceDirect
Access this article on ScienceDirectLinked Article
- Decreased mortality in patients prescribed vancomycin after implementation of antimicrobial stewardship programAmerican Journal of Infection ControlVol. 45Issue 11